Sensyne Health and the University of Oxford’s Big Data Institute to Establish World-leading Research Alliance

Two NHS trusts sign agreements with Sensyne Health

Healthcare technology company signs SRAs with NHS Trusts

Sensyne Health and George Eliot Hospital NHS Trust sign strategic research agreement

How a £2.5m research deal will help patients at Nuneaton hospital

Jefferson to test British company's augmented intelligence technology

Partnerships give Sensyne Health a boost

Sensyne signs US agreement

Sensyne to form data science and clinical AI partnerships for chronic disease

Sensyne Health shares jump on maiden results and string of deals

AI health firm publishes first results since IPO

Lord Drayson’s AI venture ‘making strong progress’

Britain needs to step up to win the global AI healthcare race

NHS needs national aid to cash in on its data

Sensyne Welcomes Patient Data Use Endorsement From UK Government

U.K. sets out digital, data-driven plan to accelerate R&D

Nimble biotechs become vital partners for large pharma groups

Sensyne Health marries healthcare with AI

Prof Lionel Tarassenko and Prof Eric Topol contrast the precision monitoring of jet engines with monitoring systems in patients

GDm-Health™ patient app-to-clinician software system featured on BBC South Today

Sensyne Health launches new software product in five NHS Trusts in UK

AI app for gestational diabetes adopted by NHS

Sensyne’s gestational diabetes AI app launches on the NHS

NHS adopts AI app for gestational diabetes

Drug Hunters and Centaur Chemists: How AI is fundamentally changing the way Big Pharma discovers drugs

MIDAS SHARE TIPS: If you want healthy profits consider the firm seeking cures using NHS records

Senior appointment at Lord Drayson's healthcare tech firm

Sensyne Health appoints Lionel Tarassenko as Non-Executive Director

Sensyne Health highlighted in BioSpace’s recent survey on Top 5 Trends in the Life Sciences Industry

Rethink needed over use of automated health records

Two defensive income funds and one speculative growth portfolio – all worth holding

Sensyne Health welcomes code on data-driven health and care technologies

Sensyne Health featured on BBC Radio 4's 'Today' programme (47m:50s)

NHS set to be offered a ‘fair share’ of data profits

The NHS needs to cash in on data drive

Sensyne Health has healthy start to life on the stock market

Peer holds key to unlock the value of NHS patient data

Sensyne Health begins trading on AIM (Bloomberg Daybreak: Europe)

Sensyne Health makes positive debut on AIM

Sensyne Health makes solid start on AIM debut

Sensyne Health senses $76m IPO

NHS ‘owes it to society to make money from patients’ information’

Lord Drayson’s Sensyne Health raise £60m in float

Sensyne Health CEO Drayson says IPO will see AI group to profitability

Former minister Lord Drayson drives AI health trailblazer to £160m listing

Drayson floats medical AI group Sensyne Health on AIM

Sensyne Health/AI: doctored data

Sensyne Health sets AIM IPO price at 175p per share, giving it an initial market cap of £225m

Sensyne Health signs exclusive licence agreement for a digital health software product, Support-HF

Lord Drayson: I want to build a world-leading tech company

Sensyne Health collaborates to improve Support-HF software product

Biotech entrepreneur Drayson plans to list new AI drug research firm

Sensyne Health planning to raise £60m via AIM IPO according to founder Paul Drayson

AI data miner Sensyne Health looks to go public with $77M listing

Sensyne Health extends its agreement with Oxford University Hospitals

Mining real world data for drug development insights, Woodford-backed AI firm seeks $77M London IPO

AI healthtech start-up pressing ahead with IPO

Medtech and the Internet of Medical Things: How connected medical devices are transforming health care, featuring GDm-Health on page 30.

If NHS patient data is worth £10 billion, put it on the balance sheet and save lives too

UK digital health start-up to commercialise products with NHS

Former UK science minister Lord Drayson explains his plans for Sensyne Health, an Oxford, UK-based AI-focused healthcare technology company

There is no reason why rich, machine-learning friendly datasets from public services should be free to access for AI companies.

The unique collaboration between Drayson Health, the University of Oxford and the NHS Foundation Trust cited as the exemplar framework for using NHS data

Sharing our data could help to fund the NHS — all it needs is for us to say yes

Women's Healthcare Comes Out Of The Shadows: Femtech Shows The Way To Billion-Dollar Opportunities

Self-monitoring solution for gestational diabetes shows promise in trials

Professor David Clifton made Research Director of digital health developer Drayson Health

Evidence-based patient-to-clinican app to help support increasing burden of gestational diabetes

The UK cannot compete in the digital age without top universities

NHS seal of approval for gestational diabetes app

'Ground-breaking' deal in Oxford sees NHS products commercialised

Sky's Alex Morgan gets an exclusive look at the tablet tech at John Radcliffe Hospital

NHS to start prescribing health apps that help manage conditions

UK digital health start-up to commercialise products with NHS